A new preprint study shows the shingles vaccine reduces hospital-coded shingles but not dementia risk over eight years. The study has methodological strengths but significant limitations, notably in data completeness regarding dementia diagnoses. Anti-vaxxers use this unpublished study to challenge… Read More »Review of study that refutes shingles vaccine effect on dementia
A recent study indicates that recipients of the recombinant shingles vaccine (Shingrix) experience a lower risk of cardiovascular events compared to those who received the live-attenuated vaccine (Zostavax). While causality is not established, Shingrix may also provide ancillary benefits, including… Read More »Recombinant shingles vaccine improves cardiovascular outcomes
A cohort study indicates that older adults at risk for dementia have a reduced likelihood of receiving a dementia diagnosis after vaccination with the herpes zoster (shingles) vaccine. The study found a 24% lower dementia risk among vaccinated individuals, reinforcing… Read More »Lower risk of dementia after shingles vaccine in the high-risk group
A recent study confirms that the shingles vaccine, Shingrix, significantly lowers the risk of developing dementia, Alzheimer’s disease, and vascular dementia in older adults. The findings suggest a correlation between vaccination and reduced cognitive decline risk, emphasizing the vaccine’s broader… Read More »Another large study shows shingles vaccine lowers risk of dementia
A recent study indicates a link between the shingles vaccine and slower biological aging, revealing benefits like reduced inflammation and improved immune response. While the vaccine primarily prevents shingles, its potential effects on healthy aging are noteworthy. However, the study… Read More »Study shows that the shingles vaccine promotes healthy aging
Recent research from Canada indicates that the shingles vaccine may significantly reduce dementia risk. The study analyzed a quasi-randomized rollout of the vaccine, linking eligibility with a 2% lower likelihood of new dementia diagnoses over 5.5 years. While the exact… Read More »Another study shows shingles vaccine reduces risk of dementia
In 2025, the author reflects on their tradition of listing the top 10 most-viewed articles, revealing readers’ continued interest in vaccines. Key topics include vaccine impacts on lupus, dementia, and heart health. The article highlights ongoing misinformation and reaffirms the… Read More »Top 10 most viewed articles on Skeptical Raptor during 2025
Vaccines are vital in preventing infectious diseases and chronic conditions such as cancer and dementia. The HPV and hepatitis B vaccines are particularly effective in reducing cancer risks, while the shingles vaccine may lower dementia incidence. Vaccines also help manage… Read More »Vaccines that protect against chronic diseases and even cancer
The article highlights the effectiveness of the shingles vaccine, linking it to lower rates of dementia-related deaths. A recent study shows that dementia patients who received the older Zostavax vaccine experienced a 29.5% decrease in deaths over nine years. The… Read More »Shingles vaccine linked to a lower rate of dementia-related deaths
A recent study reveals that shingles increases the risk of major cardiovascular events by 25%. However, those vaccinated against shingles showed a significant reduction in these risks, including heart attacks and dementia. The shingles vaccine, recommended for individuals 50 and… Read More »Shingles vaccine reduces risk of heart attacks, dementia, and death